{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:31:08Z","timestamp":1769560268143,"version":"3.49.0"},"reference-count":41,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T00:00:00Z","timestamp":1725580800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Multiple sclerosis (MS) is a chronic autoimmune disease with an unknown etiology. The purpose of this research was to assess miR-223, miR-146a, and miR-193a in acute and chronic phases of experimental autoimmune encephalomyelitis (EAE) mice to consider the possible role of these genes in the pathogenesis of MS. EAE induction was given by myelin oligodendrocyte glycoprotein peptide on female C57BL\/6 mice. Clinical scores and other criteria were followed daily until day 21 for the acute group and day 77 for the chronic group. At the end of the course, inflammation and demyelination of the central nervous system (CNS) were assessed by histological analysis. MicroRNA expression levels were assessed by real-time PCR. EAE development attenuated in the chronic group, and histological analysis showed less infiltration and demyelination in the chronic group compared to the acute group. The upper expression of miR-223 is demonstrated in the acute phase of EAE. Moreover, the expression levels of miR-146a and miR-193a decreased in the chronic phase of EAE. MiR-223 showed a highly coordinated elevation in the acute phase both in vivo and in vitro. MiR-146a shares a pathway with miR-223 through effecting IL-6 expression. Further studies are needed to reveal their impact on EAE and possible applications as drug targets and biomarkers.<\/jats:p>","DOI":"10.3390\/cells13171499","type":"journal-article","created":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T07:42:06Z","timestamp":1725608526000},"page":"1499","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Dysregulation of miR-223, miR-146a, and miR-193a Expression Profile in Acute and Chronic Phases of Experimental Autoimmune Encephalomyelitis in C57BL\/6 Mice"],"prefix":"10.3390","volume":"13","author":[{"given":"Saba","family":"Gharibi","sequence":"first","affiliation":[{"name":"Institute for Physical Activity and Nutrition, School of Exercise and Nutrition Sciences, Deakin University 1 Gheringhap Street, Geelong, VIC 3220, Australia"},{"name":"Department of Genetics, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bahram","family":"Moghimi","sequence":"additional","affiliation":[{"name":"Department of Genetics, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Bagher","family":"Mahmoudi","sequence":"additional","affiliation":[{"name":"Research and Development Department, ROJETechnologies, Yazd, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ensieh","family":"Shahvazian","sequence":"additional","affiliation":[{"name":"Research and Development Department, ROJETechnologies, Yazd, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ehsan Farashahi","family":"Yazd","sequence":"additional","affiliation":[{"name":"Department of Genetics, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Yadegari","sequence":"additional","affiliation":[{"name":"Department of Biology and Anatomical Sciences, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Taher","family":"Tahoori","sequence":"additional","affiliation":[{"name":"Department of Immunology, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esmaeil","family":"Yazdanpanah","sequence":"additional","affiliation":[{"name":"Department of Immunology, School of Medicine, Semnan University of Medical Sciences, Semnan, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9876-4943","authenticated-orcid":false,"given":"Dariush","family":"Haghmorad","sequence":"additional","affiliation":[{"name":"Department of Immunology, School of Medicine, Semnan University of Medical Sciences, Semnan, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5088-3791","authenticated-orcid":false,"given":"Valentyn","family":"Oksenych","sequence":"additional","affiliation":[{"name":"Broegelmann Research Laboratory, Department of Clinical Science, University of Bergen, 5020 Bergen, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,9,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Sandi, D., Fricska-Nagy, Z., Bencsik, K., and V\u00e9csei, L. (2021). Neurodegeneration in multiple sclerosis: Symptoms of silent progression, biomarkers and neuroprotective therapy\u2014Kynurenines are important players. Molecules, 26.","DOI":"10.3390\/molecules26113423"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/jnr.24224","article-title":"Animal models of multiple sclerosis: Focus on experimental autoimmune encephalomyelitis","volume":"96","author":"Bjelobaba","year":"2018","journal-title":"J. Neurosci. Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.msard.2011.09.002","article-title":"Experimental in vivo and in vitro models of multiple sclerosis: EAE and beyond","volume":"1","author":"Kipp","year":"2012","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"915","DOI":"10.2174\/1871527314666150716103629","article-title":"Defining and regulating acute inflammatory lesion formation during the pathogenesis of multiple sclerosis and experimental autoimmune encephalomyelitis","volume":"14","author":"Bolton","year":"2015","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1073\/pnas.1222426110","article-title":"Eriocalyxin B ameliorates experimental autoimmune encephalomyelitis by suppressing Th1 and Th17 cells","volume":"110","author":"Lu","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jaut.2019.04.002","article-title":"Small non-coding RNAs as important players, biomarkers and therapeutic targets in multiple sclerosis: A comprehensive overview","volume":"101","author":"Piket","year":"2019","journal-title":"J. Autoimmun."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"810","DOI":"10.7150\/ijms.8647","article-title":"Expression, regulation and function of microRNAs in multiple sclerosis","volume":"11","author":"Ma","year":"2014","journal-title":"Int. J. Med. Sci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.autrev.2010.07.002","article-title":"MicroRNAs in autoimmunity and inflammatory bowel disease: Crucial regulators in immune response","volume":"11","author":"Iborra","year":"2012","journal-title":"Autoimmun. Rev."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Chandan, K., Gupta, M., and Sarwat, M. (2020). Role of host and pathogen-derived microRNAs in immune regulation during infectious and inflammatory diseases. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.03081"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Amoruso, A., Blonda, M., Gironi, M., Grasso, R., Di Francescantonio, V., Scaroni, F., Furlan, R., Verderio, C., and Avolio, C. (2020). Immune and central nervous system-related miRNAs expression profiling in monocytes of multiple sclerosis patients. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-63282-3"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Saba, R., Sorensen, D.L., and Booth, S.A. (2014). MicroRNA-146a: A dominant, negative regulator of the innate immune response. Front. Immunol., 5.","DOI":"10.3389\/fimmu.2014.00578"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"160","DOI":"10.2174\/1871524922666220929153215","article-title":"Neuroinflammation: Molecular mechanisms and therapeutic perspectives","volume":"22","author":"Marino","year":"2022","journal-title":"Cent. Nerv. Syst. Agents Med. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.imlet.2021.07.004","article-title":"Efficient roles of miR-146a in cellular and molecular mechanisms of neuroinflammatory disorders: An effectual review in neuroimmunology","volume":"238","author":"Aslani","year":"2021","journal-title":"Immunol. Lett."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"28","DOI":"10.21037\/ncri.2018.04.06","article-title":"MicroRNAs in cell cycle progression and proliferation: Molecular mechanisms and pathways","volume":"2","author":"Rodrigues","year":"2018","journal-title":"Non-Coding RNA Investig."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"16861","DOI":"10.1002\/jcp.28368","article-title":"miR-193: A new weapon against cancer","volume":"234","author":"Khordadmehr","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Thirugnanasambantham, K., Islam, V.I.H., Saravanan, S., Kumar, V.S., Ashok, G., and Chellappandian, M. (2018). Role of miRNA in Multiple Sclerosis. MicroRNA: Perspectives in Health and Diseases, CRC Press.","DOI":"10.1201\/b22195-4"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/glia.21082","article-title":"Modulation of adult hippocampal neurogenesis during myelin-directed autoimmune neuroinflammation","volume":"59","author":"Huehnchen","year":"2011","journal-title":"Glia"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3109\/08923970903338367","article-title":"Therapeutic effect of EDTA in experimental model of multiple sclerosis","volume":"32","author":"Mosayebi","year":"2010","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"185","DOI":"10.5001\/omj.2014.46","article-title":"Calcium intervention ameliorates experimental model of multiple sclerosis","volume":"29","author":"Haghmorad","year":"2014","journal-title":"Oman Med. J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"273","DOI":"10.55782\/ane-2022-026","article-title":"Daphnetin alleviates experimental autoimmune encephalomyelitis by suppressing Th1 and Th17 cells and upregulating Th2 and regulatory T cells","volume":"82","author":"Soltanmohammadi","year":"2022","journal-title":"Acta Neurobiol. Exp."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1742-2094-10-120","article-title":"Inflammatory demyelination Induces glia alterations and ganglion cell loss in the retina of an experimental autoimmune encephalomyelitis model","volume":"10","author":"Horstmann","year":"2013","journal-title":"J. Neuroinflamm."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1742-2094-10-89","article-title":"Reduction of microglial activity in a model of multiple sclerosis by dipyridamole","volume":"10","author":"Sloka","year":"2013","journal-title":"J. Neuroinflamm."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/cen3.12271","article-title":"Epigenetics in multiple sclerosis","volume":"6","author":"Miyazaki","year":"2015","journal-title":"Clin. Exp. Neuroimmunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1749-8104-5-25","article-title":"Context-dependent functions of specific microRNAs in neuronal development","volume":"5","author":"Gao","year":"2010","journal-title":"Neural Dev."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"NS20170112","DOI":"10.1042\/NS20170112","article-title":"Extracellular microRNAs as messengers in the central and peripheral nervous system","volume":"1","author":"Scott","year":"2017","journal-title":"Neuronal Signal."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"18962","DOI":"10.1073\/pnas.1121288109","article-title":"MicroRNA-223 is neuroprotective by targeting glutamate receptors","volume":"109","author":"Harraz","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/imm.12611","article-title":"MicroRNA223 promotes pathogenic T-cell development and autoimmune inflammation in central nervous system in mice","volume":"148","author":"Satoorian","year":"2016","journal-title":"Immunology"},{"key":"ref_28","first-page":"371","article-title":"Upregulation of CD4+T-Cell Derived MiR-223 in The Relapsing Phase of Multiple Sclerosis Patients","volume":"18","author":"Hosseini","year":"2016","journal-title":"Cell J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.4049\/jimmunol.1501965","article-title":"Cutting Edge: MicroRNA-223 Regulates Myeloid Dendritic Cell-Driven Th17 Responses in Experimental Autoimmune Encephalomyelitis","volume":"196","author":"Ifergan","year":"2016","journal-title":"J. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"4375","DOI":"10.3390\/ijms14034375","article-title":"Expression and Genetic Analysis of MicroRNAs Involved in Multiple Sclerosis","volume":"14","author":"Ridolfi","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00401-016-1621-6","article-title":"Mir-223 regulates the number and function of myeloid-derived suppressor cells in multiple sclerosis and experimental autoimmune encephalomyelitis","volume":"133","author":"Cantoni","year":"2017","journal-title":"Acta Neuropathol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"12481","DOI":"10.1073\/pnas.0605298103","article-title":"NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses","volume":"103","author":"Taganov","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_33","first-page":"792","article-title":"miR-146a and miR-155 expression in PBMCs from patients with Sjogren\u2019s syndrome","volume":"43","author":"Shi","year":"2014","journal-title":"J. Oral Pathol. Med. Off. Publ. Int. Assoc. Oral Pathol. Am. Acad. Oral Pathol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/art.24436","article-title":"MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins","volume":"60","author":"Tang","year":"2009","journal-title":"Arthritis Rheum."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"R81","DOI":"10.1186\/ar3006","article-title":"Altered microRNA expression profile with miR-146a upregulation in CD4(+) T cells from patients with rheumatoid arthritis","volume":"12","author":"Li","year":"2010","journal-title":"Arthritis Res. Ther."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jneuroim.2012.02.012","article-title":"MicroRNA regulation in experimental autoimmune encephalomyelitis in mice and marmosets resembles regulation in human multiple sclerosis lesions","volume":"246","author":"Lescher","year":"2012","journal-title":"J. Neuroimmunol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000369695","article-title":"Genetic Association of MiR-146a with Multiple Sclerosis Susceptibility in the Chinese Population","volume":"35","author":"Li","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"R101","DOI":"10.1186\/ar2493","article-title":"Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients","volume":"10","author":"Pauley","year":"2008","journal-title":"Arthritis Res. Ther."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Niimoto, T., Nakasa, T., Ishikawa, M., Okuhara, A., Izumi, B., Deie, M., Suzuki, O., Adachi, N., and Ochi, M. (2010). MicroRNA-146a expresses in interleukin-17 producing T cells in rheumatoid arthritis patients. BMC Musculoskelet. Disord., 11.","DOI":"10.1186\/1471-2474-11-209"},{"key":"ref_40","first-page":"5913195","article-title":"Biological Function of MicroRNA193a-3p in Health and Disease","volume":"2017","author":"Grossi","year":"2017","journal-title":"Int. J. Genom."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Otaegui, D., Baranzini, S.E., Arma\u00f1anzas, R., Calvo, B., Mu\u00f1oz-Culla, M., Khankhanian, P., Inza, I., Lozano, J.A., Castillo-Trivi\u00f1o, T., and Asensio, A. (2009). Differential micro RNA expression in PBMC from multiple sclerosis patients. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0006309"}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/13\/17\/1499\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:49:48Z","timestamp":1760111388000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/13\/17\/1499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,6]]},"references-count":41,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["cells13171499"],"URL":"https:\/\/doi.org\/10.3390\/cells13171499","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,6]]}}}